Hemoconcentrators, also referred to as hemofilters or ultrafiltration devices, which contain a semipermeable membrane that allows passage of water and electrolytes out of the blood. They are used in lieu of diuretics to remove excess fluid or electrolytes and to raise the hematocrit of the perfusate. Hemoconcentrators can be connected to the cardiopulmonary bypass circuit (CPB) in different configurations. Blood can be drawn from the venous line, the arterial line, or the systemic flow line, and the filtered blood may be transferred through the venous line or the cardiotomy or venous reservoirs. However, when blood is drawn from the high pressure line (e.g. systemic flow line), a pump is required to propel the blood through the device. Removal of fluid can be up to 180ml/min (at a flow of 500ml/min); however, it is often in the range of 30 ml/min to 50 ml/min.
Strong expertise with attention to detail makes our market research reports stand apart, Request a Report sample @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34430
Hemoconcentrators can be used after CPB to concentrate the pumped blood before it is transferred back to the patient either through a bag or directly through the patient’s venous line. Unlike cell savers, hemoconcentrators conserve platelets, albumin, and coagulation factors. However, hemoconcentrated blood contains heparin which is required to be neutralized with the help of protamine before infusion. Hemoconcentrators can be easily controlled and do not cause excessive loss of potassium.
The global adult and pediatric hemoconcentrators market is undergoing a significant growth due to the increase in prevalence of cardiac diseases requiring intensive treatment, rise in geriatric population, and technological advancements in fluid management. It is also developing rapidly owing to the participation of several new players in the market. The new entrants are focusing on new technologies and launching of new products in the market. According to the WHO, cardiovascular diseases are the leading cause of death across the world. Around 17.5 million people died due to cardiovascular diseases in 2012. Out of these, more than 7.4 million deaths were caused by coronary heart diseases and 6.7 million by stroke. The escalating number of people suffering from cardiovascular diseases is expected to augment the adult and pediatric hemoconcentrators market in the near future. The adult and pediatric hemoconcentrators market can be segmented based on type, end-user, and region. On the basis of type, the market can be further classified into adult hemoconcentrators and pediatric hemoconcentrators. By end-user, the market can be divided into hospitals, ambulatory surgical centers, and others.
Pre Book Adult and Pediatric Hemoconcentrators Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=34430<ype=S
Geographically, the adult and pediatric hemoconcentrators market can been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share of the adult and pediatric hemoconcentrators market due to the high adoption rate of technologically enhanced instruments, increase in cell-based research activities, rise in disposable income, and advanced healthcare infrastructure in the region. Europe accounts for the second largest market, in terms of revenue, owing to the significant investments in healthcare and rise in geriatric population. Asia Pacific is expected to expand at high CAGR during the forecast period due to the increase in prevalence of cardiovascular diseases in the region. According to the Organisation for Economic Co-operation and Development (OECD), cardiovascular diseases are the leading cause of death in Asia Pacific; although they are preventable. Cardiovascular diseases caused an estimated 9.3 million deaths in the region and accounted for about one-third of the total deaths in 2012. Latin America and Middle East & Africa are expected to be the prospective markets in the near future for adult and pediatric hemoconcentrators due to the high adoption rate of precise analytical instruments and the rapidly developing pharmaceutical and biotechnology industry.
Request COVID Analysis on Adult and Pediatric Hemoconcentrators Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=34430
Some of the key players operating in adult and pediatric hemoconcentrators market are Medtronic, ANDOCOR n.v., Terumo Cardiovascular Systems Corporation, Sorin Group, MEDIVATORS Inc., and MAQUET Holding B.V. & Co. KG.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to industry leaders, consultants, and strategy professionals.
Our reports are single-point solutions for industries to grow, evolve, and mature. Our significant-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These demands are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for client-specific problems with right methodology of research is the key to help enterprises reach right decision.
U.S. Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com
Dr. Qasim Husain, a New Jersey native, is an ENT who completed his undergraduate and medical education in the accelerated 7-year BS/MD program at Rutgers New Jersey Medical School.
He then completed residency in Otolaryngology-Head and Neck Surgery at NewYork-Presbyterian Hospital/ Columbia and Cornell University, as well as Memorial Sloan Kettering Cancer Center.
Subsequently, he pursued advanced fellowship training in Rhinology (Sinus and Skull Base Surgery) at Massachusetts Eye and Ear/ Harvard Medical School.
He is a certified Pediatric and Adult Otolaryngologist.
